These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34144890)

  • 1. Investigating the release of inflammatory cytokines in a human model of incontinence-associated dermatitis.
    Koudounas S; Bader DL; Voegeli D
    J Tissue Viability; 2021 Aug; 30(3):427-433. PubMed ID: 34144890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the presence of bacterial urinary infection contribute to the development of incontinence-associated dermatitis? A scoping review.
    Koudounas S; Mugita Y; Minematsu T; Nakagami G; Weller C; Sanada H
    J Tissue Viability; 2021 May; 30(2):256-261. PubMed ID: 33579585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incontinence-associated dermatitis: who is affected?
    Pather P; Doubrovsky A; Jack L; Coyer F
    J Wound Care; 2021 Apr; 30(4):261-267. PubMed ID: 33856906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in inflammatory cytokine levels following synthetic cathinone self-administration in rats.
    Marusich JA; Gay EA; Stewart DA; Blough BE
    Neurotoxicology; 2022 Jan; 88():65-78. PubMed ID: 34742947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultivating Incontinence-associated Dermatitis Prevention Practices in an Australian Local Health District: A Quasi-experimental Study.
    Barakat-Johnson M; Lai M; Wand T; Coyer F; White K
    Ostomy Wound Manage; 2018 Dec; 64(12):16-28. PubMed ID: 30516479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra.
    Hutchinson PJ; O'Connell MT; Rothwell NJ; Hopkins SJ; Nortje J; Carpenter KL; Timofeev I; Al-Rawi PG; Menon DK; Pickard JD
    J Neurotrauma; 2007 Oct; 24(10):1545-57. PubMed ID: 17970618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical challenges of preventing incontinence-associated dermatitis.
    Beeckman D; Woodward S; Rajpaul K; Vanderwee K
    Br J Nurs; 2011 Jul 15-28; 20(13):784-6,788,790. PubMed ID: 21841685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation.
    Perkins MA; Osterhues MA; Farage MA; Robinson MK
    Skin Res Technol; 2001 Nov; 7(4):227-37. PubMed ID: 11737818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incontinence-associated dermatitis: reducing adverse events.
    Rippon M; Colegrave M; Ousey K
    Br J Nurs; 2016 Oct; 25(18):1016-1021. PubMed ID: 27734729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the varying management of incontinence-associated dermatitis due to a lack of understanding of etiology?
    Porter M
    Br J Community Nurs; 2024 May; 29(Sup5):S34-S36. PubMed ID: 38728164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incontinence-associated dermatitis: new insights into an old problem.
    Voegeli D
    Br J Nurs; 2016 Mar 10-23; 25(5):256, 258, 260-2. PubMed ID: 26972998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge Gaps in the Etiology and Pathophysiology of Incontinence-Associated Dermatitis: A Scoping Review.
    Koudounas S; Bader DL; Voegeli D
    J Wound Ostomy Continence Nurs; 2020; 47(4):388-395. PubMed ID: 33290017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incontinence-associated dermatitis in older adults in residential care settings: a point prevalence study.
    Wall B; Kelly AM; White P; McCann M
    Br J Nurs; 2024 May; 33(9):S16-S28. PubMed ID: 38722011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incontinence-associated dermatitis: step-by-step prevention and treatment.
    Beeckman D; Woodward S; Gray M
    Br J Community Nurs; 2011 Aug; 16(8):382-9. PubMed ID: 21841630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incontinence-Associated Dermatitis (IAD): Prevalence and Associated Factors in 4 Hospitals in Southeast Norway.
    Johansen E; Bakken LN; Duvaland E; Faulstich J; Hoelstad HL; Moore Z; Vestby EM; Beeckman D
    J Wound Ostomy Continence Nurs; 2018; 45(6):527-531. PubMed ID: 30395129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing absorbent products' effectiveness for the prevention and management of incontinence-associated dermatitis caused by urinary, faecal or double adult incontinence: A systematic review.
    Mugita Y; Koudounas S; Nakagami G; Weller C; Sanada H
    J Tissue Viability; 2021 Nov; 30(4):599-607. PubMed ID: 34376333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time of Onset to Changes in Skin Condition During Exposure to Synthetic Urine: A Prospective Study.
    Phipps L; Gray M; Call E
    J Wound Ostomy Continence Nurs; 2019; 46(4):315-320. PubMed ID: 31274862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-invasive tape absorption method for recovery of inflammatory mediators to differentiate normal from compromised scalp conditions.
    Perkins MA; Cardin CW; Osterhues MA; Robinson MK
    Skin Res Technol; 2002 Aug; 8(3):187-93. PubMed ID: 12236889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and management of incontinence-associated dermatitis.
    Nix D; Haugen V
    Drugs Aging; 2010 Jun; 27(6):491-6. PubMed ID: 20524708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.